Limitations, agreements, and source contact

Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma · Source last updated 2016-02-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

omuroa@mskcc.org

organization

Memorial Sloan Kettering Cancer Center

phone

212 639 7523

title

Dr. Antonio Omuro

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice